Back to Search
CHANDRA BELANI, MD
MD
Hematology & Oncology Physician
NPI: 1659343895Individual
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD042384E(PA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD042384E(PA)
Research & Publications (20)
Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
PMID 18816622·Cancer·2008
3-trial
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
PMID 18202422·J Clin Oncol·2008
3-trial
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research.
PMID 17084482·Lung Cancer·2007
6-review
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
PMID 17043094·Ann Oncol·2007
3-trial
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
PMID 16787687·Lung Cancer·2006
2-rct
Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
PMID 15837967·J Clin Oncol·2005
3-trial
Adjuvant and neoadjuvant therapy in non-small cell lung cancer.
PMID 15818538·Semin Oncol·2005
6-review
Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
PMID 16288485·Cancer·2005
3-trial
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
PMID 16557668·Lung Cancer·2005
6-review
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
PMID 15723261·Cancer Chemother Pharmacol·2005
3-trial
Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
PMID 16087941·J Clin Oncol·2005
3-trial
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.
PMID 15860487·Ann Oncol·2005
3-trial
Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
PMID 15726531·Semin Oncol·2004
6-review
Development of docetaxel in advanced non-small-cell lung cancer.
PMID 15698529·Lung Cancer·2004
6-review
Integration of docetaxel in the management of non-small-cell lung cancer.
PMID 15698526·Lung Cancer·2004
8-other
Emerging role of erlotinib (OSI-774) in non-small-cell lung cancer.
PMID 15638958·Clin Lung Cancer·2004
8-other
Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group.
PMID 15310416·Clin Lung Cancer·2004
3-trial
Newer cytotoxic and targeted agents are advancing the treatment of lung cancer.
PMID 14720335·Clin Lung Cancer·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 UNIVERSITY DR
HERSHEY, PA 17033 - Phone
- (717) 531-6585
Quick Facts
- NPI
- 1659343895
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile